0000899243-18-020659.txt : 20180726
0000899243-18-020659.hdr.sgml : 20180726
20180726162737
ACCESSION NUMBER: 0000899243-18-020659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180724
FILED AS OF DATE: 20180726
DATE AS OF CHANGE: 20180726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koppel Adam
CENTRAL INDEX KEY: 0001578965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972075
MAIL ADDRESS:
STREET 1: C/O BROOKSIDE CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON ST
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwartz Jeffrey Lawrence
CENTRAL INDEX KEY: 0001702957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972076
MAIL ADDRESS:
STREET 1: C/O BAIN CAPITAL LIFE SCIENCES, LP
STREET 2: 200 CLARENDON STRERET
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BCIP Life Sciences Associates, LP
CENTRAL INDEX KEY: 0001702921
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972077
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund, L.P.
CENTRAL INDEX KEY: 0001687968
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972078
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-516-2000
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Partners, LP
CENTRAL INDEX KEY: 0001703030
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972079
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC
CENTRAL INDEX KEY: 0001703031
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 18972080
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-995-2443
MAIL ADDRESS:
STREET 1: 18 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-24
1
0001737953
Replimune Group, Inc.
REPL
0001703031
Bain Capital Life Sciences Investors, LLC
200 CLARENDON STREET
BOSTON
MA
02116
0
0
1
0
0001703030
Bain Capital Life Sciences Partners, LP
200 CLARENDON STREET
BOSTON
MA
02116
0
0
1
0
0001687968
Bain Capital Life Sciences Fund, L.P.
200 CLARENDON STREET
BOSTON
MA
02116
0
0
1
0
0001702921
BCIP Life Sciences Associates, LP
200 CLARENDON STREET
BOSTON
MA
02116
0
0
1
0
0001702957
Schwartz Jeffrey Lawrence
200 CLARENDON STREET
BOSTON
MA
02116
0
0
1
0
0001578965
Koppel Adam
C/O BAIN CAPITAL LIFE SCIENCES INVESTORS
200 CLARENDON STREET
BOSTON
MA
02116
1
0
0
0
Common Stock
2018-07-24
4
C
0
2338968
A
2338968
I
See Footnotes
Common Stock
2018-07-24
4
P
0
500000
15.00
A
2838968
I
See Footnotes
Series B Convertible Preferred Stock
2018-07-24
4
C
0
235146
D
Common Stock
2338968
0
I
See footnotes
Represents shares held directly by Bain Capital Life Sciences Fund, L.P. and BCIP Life Sciences Associates, LP (collectively, the "Bain Life Sciences Entities").
The governance, investment strategy and decision-making process with respect to investments held by the Bain Life Sciences Entities is directed by Bain Capital Life Sciences Investors, LLC ("BCI LS"), whose managers are Jeffrey Schwartz and Adam Koppel. As a result, BCI LS, Mr. Schwartz and Dr. Koppel may each be deemed to share voting and dispositive power with respect to the securities held by the Bain Life Sciences Entities. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Each share of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1-for-9.94688 basis upon the consummation of the Issuer's initial public offering without payment or additional consideration. The shares of Series B Convertible Preferred Stock had no expiration date.
On July 24, 2018, the Bain Life Sciences Entities purchased, in aggregate, 500,000 shares of Common Stock of the Issuer at a price of $15 per share, pursuant to an underwritten public offering.
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, By: /s/ Adam Koppel, Name: Adam Koppel, Title: Managing Director
2018-07-26
BAIN CAPITAL LIFE SCIENCES PARTNERS, LP, By: Bain Capital Life Sciences Investors, LLC, its general partner, By: /s/ Adam Koppel, Name: Adam Koppel, Title: Managing Director
2018-07-26
BAIN CAPITAL LIFE SCIENCES FUND, L.P., By: Bain Capital Life Sciences Partners, LP, its general partner, By: Bain Capital Life Sciences Investors, LLC, its general partner, By: /s/ Adam Koppel, Name: Adam Koppel, Title: Managing Director
2018-07-26
BCIP LIFE SCIENCES ASSOCIATES, LP, By: Boylston Coinvestors, LLC, its general partner, By: /s/ Adam Koppel, Name: Adam Koppel, Title: Authorized Signatory
2018-07-26
/s/ Jeffrey Schwartz
2018-07-26
/s/ Adam Koppel
2018-07-26